论文部分内容阅读
免疫性血小板减少性紫癜(ITP)常用疗法包括皮质醇激素(CS)、脾切除术(SX)和免疫抑制剂(IS)。以往报告的病例数常有限,随访时间可能较短,由于短时间随访,遂导致对疗效产生过份乐观印象,以及延缓其它治疗手段的应用,并可能错误估价其疗效。本组随访时间最少12个月,许多病人超过10年。 168例中成人90例,儿童78例;男79例,女89例。继发性22例。中数随访时间75个月(随访时间为12-120个月以上)。用CS治疗125例、SX83例、IS25例;43例未用上述疗法。
Common treatments for immune thrombocytopenic purpura (ITP) include cortisol (CS), splenectomy (SX), and immunosuppressive agents (IS). The number of previously reported cases is often limited and the duration of follow-up may be short, resulting in an overly optimistic impression of efficacy, shortening the use of other therapies due to short follow-up, and possibly erroneously assessing their efficacy. This group was followed up for at least 12 months, many patients more than 10 years. Among 168 cases, 90 were adults and 78 were children. There were 79 males and 89 females. Secondary cases in 22 cases. The median follow-up time 75 months (follow-up time of 12-120 months). 125 cases treated with CS, SX83 cases, IS25 cases; 43 cases without the above treatment.